These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

675 related articles for article (PubMed ID: 29900633)

  • 41. Highly sensitive enumeration of circulating tumor cells in lung cancer patients using a size-based filtration microfluidic chip.
    Huang T; Jia CP; Jun-Yang ; Sun WJ; Wang WT; Zhang HL; Cong H; Jing FX; Mao HJ; Jin QH; Zhang Z; Chen YJ; Li G; Mao GX; Zhao JL
    Biosens Bioelectron; 2014 Jan; 51():213-8. PubMed ID: 23962709
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cytometric characterization of circulating tumor cells captured by microfiltration and their correlation to the CellSearch(®) CTC test.
    Adams DL; Stefansson S; Haudenschild C; Martin SS; Charpentier M; Chumsri S; Cristofanilli M; Tang CM; Alpaugh RK
    Cytometry A; 2015 Feb; 87(2):137-44. PubMed ID: 25515318
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A Prospective Evaluation of Circulating Tumor Cells and Cell-Free DNA in EGFR-Mutant Non-Small Cell Lung Cancer Patients Treated with Erlotinib on a Phase II Trial.
    Yanagita M; Redig AJ; Paweletz CP; Dahlberg SE; O'Connell A; Feeney N; Taibi M; Boucher D; Oxnard GR; Johnson BE; Costa DB; Jackman DM; Jänne PA
    Clin Cancer Res; 2016 Dec; 22(24):6010-6020. PubMed ID: 27281561
    [TBL] [Abstract][Full Text] [Related]  

  • 44. EGFR and HER3 expression in circulating tumor cells and tumor tissue from non-small cell lung cancer patients.
    Scharpenseel H; Hanssen A; Loges S; Mohme M; Bernreuther C; Peine S; Lamszus K; Goy Y; Petersen C; Westphal M; Glatzel M; Riethdorf S; Pantel K; Wikman H
    Sci Rep; 2019 May; 9(1):7406. PubMed ID: 31092882
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dynamic Monitoring and Predictive Value of Circulating Tumor Cells in EGFR-Mutated Advanced Non-Small-Cell Lung Cancer Patients Treated With First-Line EGFR Tyrosine Kinase Inhibitors.
    Jiang T; Zhao J; Zhao C; Li X; Shen J; Zhou J; Ren S; Su C; Zhou C; O'Brien M
    Clin Lung Cancer; 2019 Mar; 20(2):124-133.e2. PubMed ID: 30587399
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Isolation of rare circulating tumour cells in cancer patients by microchip technology.
    Nagrath S; Sequist LV; Maheswaran S; Bell DW; Irimia D; Ulkus L; Smith MR; Kwak EL; Digumarthy S; Muzikansky A; Ryan P; Balis UJ; Tompkins RG; Haber DA; Toner M
    Nature; 2007 Dec; 450(7173):1235-9. PubMed ID: 18097410
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of a marker independent isolation method for circulating tumor cells in esophageal adenocarcinoma.
    Philippron A; Depypere L; Oeyen S; De Laere B; Vandeputte C; Nafteux P; De Preter K; Pattyn P
    PLoS One; 2021; 16(5):e0251052. PubMed ID: 33961658
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Concordance of anaplastic lymphoma kinase (ALK) gene rearrangements between circulating tumor cells and tumor in non-small cell lung cancer.
    Tan CL; Lim TH; Lim TKh; Tan DS; Chua YW; Ang MK; Pang B; Lim CT; Takano A; Lim AS; Leong MC; Lim WT
    Oncotarget; 2016 Apr; 7(17):23251-62. PubMed ID: 26993609
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Enumeration and Molecular Characterization of Tumor Cells in Lung Cancer Patients Using a Novel In Vivo Device for Capturing Circulating Tumor Cells.
    Gorges TM; Penkalla N; Schalk T; Joosse SA; Riethdorf S; Tucholski J; Lücke K; Wikman H; Jackson S; Brychta N; von Ahsen O; Schumann C; Krahn T; Pantel K
    Clin Cancer Res; 2016 May; 22(9):2197-206. PubMed ID: 26667488
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A lab-on-a-disc platform enables serial monitoring of individual CTCs associated with tumor progression during EGFR-targeted therapy for patients with NSCLC.
    Lim M; Park J; Lowe AC; Jeong HO; Lee S; Park HC; Lee K; Kim GH; Kim MH; Cho YK
    Theranostics; 2020; 10(12):5181-5194. PubMed ID: 32373206
    [No Abstract]   [Full Text] [Related]  

  • 51. The predictive and prognostic significance of liquid biopsy in advanced epidermal growth factor receptor-mutated non-small cell lung cancer: A prospective study.
    Ding PN; Becker TM; Bray VJ; Chua W; Ma YF; Lynch D; Po J; Luk AWS; Caixeiro N; de Souza P; Roberts TL
    Lung Cancer; 2019 Aug; 134():187-193. PubMed ID: 31319980
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effective capture of circulating tumor cells from a transgenic mouse lung cancer model using dendrimer surfaces immobilized with anti-EGFR.
    Myung JH; Roengvoraphoj M; Tam KA; Ma T; Memoli VA; Dmitrovsky E; Freemantle SJ; Hong S
    Anal Chem; 2015 Oct; 87(19):10096-102. PubMed ID: 26312815
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sensitive detection of viable circulating tumor cells using a novel conditionally telomerase-selective replicating adenovirus in non-small cell lung cancer patients.
    Togo S; Katagiri N; Namba Y; Tulafu M; Nagahama K; Kadoya K; Takamochi K; Oh S; Suzuki K; Sakurai F; Mizuguchi H; Urata Y; Takahashi K
    Oncotarget; 2017 May; 8(21):34884-34895. PubMed ID: 28432274
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Single-Cell Phenotypic and Molecular Characterization of Circulating Tumor Cells Isolated from Cryopreserved Peripheral Blood Mononuclear Cells of Patients with Lung Cancer and Sarcoma.
    Vismara M; Reduzzi C; Silvestri M; Murianni F; Lo Russo G; Fortunato O; Motta R; Lanzoni D; Giovinazzo F; Miodini P; Pasquali S; Suatoni P; Pastorino U; Roz L; Sozzi G; Cappelletti V; Bertolini G
    Clin Chem; 2022 May; 68(5):691-701. PubMed ID: 35304611
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Capture, release and culture of circulating tumor cells from pancreatic cancer patients using an enhanced mixing chip.
    Sheng W; Ogunwobi OO; Chen T; Zhang J; George TJ; Liu C; Fan ZH
    Lab Chip; 2014 Jan; 14(1):89-98. PubMed ID: 24220648
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Label-Free Isolation and mRNA Detection of Circulating Tumor Cells from Patients with Metastatic Lung Cancer for Disease Diagnosis and Monitoring Therapeutic Efficacy.
    Wang J; Lu W; Tang C; Liu Y; Sun J; Mu X; Zhang L; Dai B; Li X; Zhuo H; Jiang X
    Anal Chem; 2015 Dec; 87(23):11893-900. PubMed ID: 26531886
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fluid biopsy for circulating tumor cell identification in patients with early-and late-stage non-small cell lung cancer: a glimpse into lung cancer biology.
    Wendel M; Bazhenova L; Boshuizen R; Kolatkar A; Honnatti M; Cho EH; Marrinucci D; Sandhu A; Perricone A; Thistlethwaite P; Bethel K; Nieva J; Heuvel Mv; Kuhn P
    Phys Biol; 2012 Feb; 9(1):016005. PubMed ID: 22307026
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Isolation and mutational analysis of circulating tumor cells from lung cancer patients with magnetic sifters and biochips.
    Earhart CM; Hughes CE; Gaster RS; Ooi CC; Wilson RJ; Zhou LY; Humke EW; Xu L; Wong DJ; Willingham SB; Schwartz EJ; Weissman IL; Jeffrey SS; Neal JW; Rohatgi R; Wakelee HA; Wang SX
    Lab Chip; 2014 Jan; 14(1):78-88. PubMed ID: 23969419
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expression of MET in circulating tumor cells correlates with expression in tumor tissue from advanced-stage lung cancer patients.
    Ilie M; Szafer-Glusman E; Hofman V; Long-Mira E; Suttmann R; Darbonne W; Butori C; Lalvée S; Fayada J; Selva E; Yu W; Marquette CH; Shames DS; Punnoose E; Hofman P
    Oncotarget; 2017 Apr; 8(16):26112-26121. PubMed ID: 28212540
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Continuous centrifugal microfluidics (CCM) isolates heterogeneous circulating tumor cells via full automation.
    Woo HJ; Kim SH; Kang HJ; Lee SH; Lee SJ; Kim JM; Gurel O; Kim SY; Roh HR; Lee J; Park Y; Shin HY; Shin YI; Lee SM; Oh SY; Kim YZ; Chae JI; Lee S; Hong MH; Cho BC; Lee ES; Pantel K; Kim HR; Kim MS
    Theranostics; 2022; 12(8):3676-3689. PubMed ID: 35664056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.